---
title: "Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.14, Implies 230% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289546201.md"
description: "Sana Biotechnology's 12-month average price target was lowered to $9.14 from $9.50 by seven analysts, with forecasts ranging between $7 and $16. Despite the cut, the consensus rating remains 'Buy' among nine covering analysts (8 Buys, 1 Hold). Based on the June 11 closing price, the new target implies approximately 230% potential upside."
datetime: "2026-06-12T04:20:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289546201.md)
  - [en](https://longbridge.com/en/news/289546201.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289546201.md)
generator: "portal-rs"
---

# Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.14, Implies 230% Upside

-   According to estimates from 7 analysts, Sana Biotechnology, Inc. stock's average price target has fallen from $9.5 to $9.14, with forecasts ranging from $7 to $16 per share
-   Based on the Jun. 11 closing price, the updated target implies approximately 230% potential upside
-   Consensus rating remains at “Buy” across 9 covering analysts, with 8 Buys, 1 Holds and 0 Sells

Explore more price target data and ratings for Sana Biotechnology, Inc. on the , and track all previous and future analyst recommendations for Sana Biotechnology, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [SANA.US](https://longbridge.com/en/quote/SANA.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Sana Biotechnology (SANA) Projected to Release Earnings on Monday](https://longbridge.com/en/news/294704650.md)
- [Alphabet Inc. Makes New $9.82 Million Investment in Sana Biotechnology, Inc. $SANA](https://longbridge.com/en/news/296188088.md)
- [Tribe Property Technologies Inc. reports Q2 results](https://longbridge.com/en/news/296953133.md)
- [LSL Pharma Group Inc. reports Q2 results](https://longbridge.com/en/news/296953883.md)
- [Does Interparfums’ (IPAR) Earnings Upgrade Hint At Deeper Strength In Its Profit Model?](https://longbridge.com/en/news/296564505.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**